207 results on '"Martynkevich, Irina"'
Search Results
2. POSTER: CML-640 Case Report of Metachronous Ph+ and Ph Myeloproliferative Neoplasms
3. MPN-386 The Role of Variants of Uncertain Significance From NGS Data for Patients With pH-Negative Myeloproliferative Neoplasms
4. POSTER: CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management
5. POSTER: MPN-386 The Role of Variants of Uncertain Significance From NGS Data for Patients With pH-Negative Myeloproliferative Neoplasms
6. POSTER: CML-483 Mutations With Unknown Clinical Significance - Another Way to Develop Resistance in Patients With CML?
7. AML-395 Genomic Landscape of Acute Myeloid Leukemia With t(8;21) and inv(16)
8. CML-483 Mutations With Unknown Clinical Significance - Another Way to Develop Resistance in Patients With CML?
9. POSTER: AML-395 Genomic Landscape of Acute Myeloid Leukemia With t(8;21) and inv(16)
10. MDS-580 Case Report of Myelodysplastic Neoplasm (MDS) Hiding Under Immune Thrombocytopenic Purpura (ITP)
11. CML-640 Case Report of Metachronous Ph+ and Ph Myeloproliferative Neoplasms
12. CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management
13. MPN-311 Clinical Case of Clonal Hemopoiesis in Patient With Splenectomy in Childhood
14. MPN-225 Next Generation Sequencing (NGS) in the Diagnosis, Prognosis and Features of the Disease in Ph-Negative Myeloproliferative Neoplasms
15. CML-401 Case Report of NGS Results in the Chronic Myeloid Leukemia Patient With Multiple Resistance to Tyrosine Kinase Inhibitors
16. CML-363 Recent Perspective of Next-Generation Sequencing (NGS) in Non-BCR:: ABL Mechanisms of Resistance in Patients With Chronic Myeloid Leukemia
17. CML-231 Long-Term Results of Tyrosine Kinase Inhibitors Discontinuation in Patients With Chronic Myeloid Leukemia
18. CML-155 Prognostic Markers of the Effectiveness of Tyrosine Kinase Inhibitors in Third-Line Therapy of Chronic Phase Chronic Myeloid Leukemia Patients: Data From a Multicenter Study
19. AML-247 Specific Features of the FLT3+ Acute Myeloid Leukemia Course
20. AML-239 Analysis of the Genomic Heterogeneity of CBF-AML Using High-Throughput Sequencing
21. P1573: EVALUATION OF THE EFFICACY OF SARS-COV-2 VACCINATION IN PATIENTS WITH FOLLICULAR LYMPHOMA DURING THE ERA OF THE COVID-19 PANDEMIC
22. PB2390: STUDY OF GENETIC ALTERATIONS USING A CUSTOM LYMPHOID TARGETED NGS PANEL IN PATIENTS WITH FOLLICULAR LYMPHOMA: A PILOT STUDY
23. P660: NEXT-GENERATION SEQUENCING (NGS) FOR DETECTING BCR::ABL-INDEPENDENT MUTATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WITH RESISTANCE TO TYROSINE KINASE INHIBITOR TREATMENT
24. PB1856: MUTATION STATUS AND ALLELE BURDEN OF FLT3-ITD IN ACUTE MYELOID LEUKEMIA
25. PB2175: NEXT-GENERATION SEQUENCING IN THE DIAGNOSIS, PROGNOSIS AND FEATURES OF THE COURSE OF THE DISEASE IN PATIENTS WITH PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
26. PB1770: CHARACTERIZATION OF THE MUTATIONAL PROFILE OF PATIENTS WITH CBF-AML - HETEROGENEITY AND IMPACT ON THE PROGNOSIS
27. Transcription of WNT Genes in Hematopoietic Niche’s Mesenchymal Stem Cells in Multiple Myeloma Patients with Different Responses to Treatment
28. Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience
29. Comparative Characteristics of the Effectiveness of Tyrosine Kinase Inhibitors Vs Allogeneic Hematopoietic Stem Cell Transplantation in the Chronic Phase of Chronic Myeloid Leukemia
30. Poster: CML-363 Recent Perspective of Next-Generation Sequencing (NGS) in Non-BCR::ABL Mechanisms of Resistance in Patients With Chronic Myeloid Leukemia
31. Poster: CML-231 Long-Term Results of Tyrosine Kinase Inhibitors Discontinuation in Patients With Chronic Myeloid Leukemia
32. Poster: MPN-311 Clinical Case of Clonal Hemopoiesis in Patient With Splenectomy in Childhood
33. CML-363 Recent Perspective of Next-Generation Sequencing (NGS) in Mechanisms of Resistance in Patients With Chronic Myeloid Leukemia
34. Poster: MPN-225 Next Generation Sequencing (NGS) in the Diagnosis, Prognosis and Features of the Disease in Ph-Negative Myeloproliferative Neoplasms
35. Poster: CML-401 Case Report of NGS Results in the Chronic Myeloid Leukemia Patient With Multiple Resistance to Tyrosine Kinase Inhibitors
36. Poster: AML-247 Specific Features of the FLT3+ Acute Myeloid Leukemia Course
37. CML-610 Mutations of Unknown Significance in the FOXO and EGFR Signaling Pathways in Patients With CML
38. MPN-608 Next-Generation Sequencing (NGS) Profiling and Cytogenetic Analysis for Patients With Ph-negative Myeloproliferative Neoplasms
39. AML-379 Molecular-Genetic Profiling of NPM1-Mutated Acute Myeloid Leukemia and Its Prognostic Value
40. Next-Generation Sequencing (NGS) Profiling and Cytogenetic Analysis for Patients With Ph-Negative Myeloproliferative Neoplasms
41. Mutations of Unknown Significance in the FOXO and EGFR Signaling Pathways in Patients With CML
42. Molecular-Genetic Profiling of NPM1-Mutated Acute Myeloid Leukemia and Its Prognostic Value
43. The combination treatment regimen of ruxolitinib with low-dose mercaptopurine or cytarabine in frail patients with blast-phase myelofibrosis
44. Next-Generation Sequencing in Non-BCR-ABLMechanisms Resistance in Patients with Chronic Myeloid Leukemia: Results of a Pilot Study
45. The Prognostic Significance of Minimal Residual Disease in Multiple Myeloma in the Molecular Genetic Groups Msmart 3.0
46. Next-Generation Sequencing Targeted Chronic Lymphocytic Leukemia Panel: A Pilot Study
47. CML-266: Second Generation Tyrosine Kinase Inhibitors in First Line Can Reduce the Time to Treatment-Free Remission in Chronic Myeloid Leukemia Patients
48. CML-366: Baseline Cytogenetic Response Level Impact on Survival of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors as Third-Line Therapy: Real-World Data in Five Russian Centers
49. Significance of Modified Risk Stratification Msmart 3.0 and Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma
50. Maintenance Therapy in Patients with Chronic Lymphocytic Leukemia Who Achieved MRD-Positive Remissions after Induction Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.